首页> 美国卫生研究院文献>Journal of Lipid Research >Intestine-specific MTP and global ACAT2 deficiency lowers acute cholesterol absorption with chylomicrons and HDLs
【2h】

Intestine-specific MTP and global ACAT2 deficiency lowers acute cholesterol absorption with chylomicrons and HDLs

机译:肠道特异性MTP和整体ACAT2缺乏会降低乳糜微粒和HDL的急性胆固醇吸收

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Intestinal cholesterol absorption involves the chylomicron and HDL pathways and is dependent on microsomal triglyceride transfer protein (MTP) and ABCA1, respectively. Chylomicrons transport free and esterified cholesterol, whereas HDLs transport free cholesterol. ACAT2 esterifies cholesterol for secretion with chylomicrons. We hypothesized that free cholesterol accumulated during ACAT2 deficiency may be secreted with HDLs when chylomicron assembly is blocked. To test this, we studied cholesterol absorption in mice deficient in intestinal MTP, global ACAT2, and both intestinal MTP and global ACAT2. Intestinal MTP ablation significantly increased intestinal triglyceride and cholesterol levels and reduced their transport with chylomicrons. In contrast, global ACAT2 deficiency had no effect on triglyceride absorption but significantly reduced cholesterol absorption with chylomicrons and increased cellular free cholesterol. Their combined deficiency reduced cholesterol secretion with both chylomicrons and HDLs. Thus, contrary to our hypothesis, free cholesterol accumulated in the absence of MTP and ACAT2 is unavailable for secretion with HDLs. Global ACAT2 deficiency causes mild hypertriglyceridemia and reduces hepatosteatosis in mice fed high cholesterol diets by increasing hepatic lipoprotein production by unknown mechanisms. We show that this phenotype is preserved in the absence of intestinal MTP in global ACAT2-deficient mice fed a Western diet. Further, we observed increases in hepatic MTP activity in these mice. Thus, ACAT2 deficiency might increase MTP expression to avoid hepatosteatosis in cholesterol-fed animals. Therefore, ACAT2 inhibition might avert hepatosteatosis associated with high cholesterol diets by increasing hepatic MTP expression and lipoprotein production.
机译:肠道胆固醇的吸收涉及乳糜微粒和HDL途径,分别取决于微粒体甘油三酸酯转移蛋白(MTP)和ABCA1。乳糜微粒运输游离的和酯化的胆固醇,而高密度脂蛋白运输游离的胆固醇。 ACAT2酯化乳糜微粒分泌的胆固醇。我们假设当乳糜微粒组装受阻时,HDLs可能会分泌ACAT2缺乏期间积累的游离胆固醇。为了测试这一点,我们研究了肠道MTP,整体ACAT2以及肠道MTP和整体ACAT2缺陷小鼠的胆固醇吸收。肠道MTP消融可显着增加肠道甘油三酯和胆固醇水平,并减少其与乳糜微粒的转运。相反,总体ACAT2缺乏对甘油三酸酯的吸收没有影响,但是与乳糜微粒显着降低了胆固醇的吸收,并增加了细胞游离胆固醇。他们的综合缺陷减少了乳糜微粒和HDLs的胆固醇分泌。因此,与我们的假设相反,在没有MTP和ACAT2的情况下积累的游离胆固醇无法与HDL一起分泌。全球ACAT2缺乏症会导致轻度高甘油三酯血症,并通过未知机制增加肝脏脂蛋白的产生,从而降低高胆固醇饮食喂养小鼠的肝脂肪变性。我们表明,这种表型在没有饲喂西方饮食的全球ACAT2缺陷小鼠中存在肠道MTP的情况下得以保留。此外,我们观察到这些小鼠的肝MTP活性增加。因此,ACAT2缺乏症可能会增加MTP表达,从而避免胆固醇喂养动物的肝脂肪变性。因此,通过增加肝脏MTP表达和脂蛋白的产生,抑制ACAT2可能避免与高胆固醇饮食相关的肝脂肪变性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号